Physician
Cardiology,
Massachusetts General Hospital
|
Clinicn Investigator, Full Prf
Cardiovascular Research Center,
Mass General Research Institute
|
Professor of Medicine
Harvard Medical School
|
alcohol septal ablation; heart septum; hypertrophic cardiomyopathy; myocardial contraction; nitroprusside; sclerosing solutions; ventricular outflow obstruction
Dr. Fifer's research focuses on hypertrophic cardiomyopathy. He introduced alcohol septal ablation, an innovative procedure for patients with hypertrophic obstructive cardiomyopathy, to the northeastern United States. He has published definitive reviews on the management of hypertrohpic cardiomyopathy in
Circulation. The research program of the Hypertrophic Cardiomyopathy Program of the Heart Center of Massachusetts General Hospital is currently conducting translational and clinical studies aimed at elucidating the pathophysiologic mechanism of hypertrophic cardiomyopathy and discovering new treatments for the disease.
